Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
J Clin Oncol 2020 Apr 10
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
Related Questions
In a patient with HR B ALL and severe pancreatitis due to peg-asparaginase, how do you assess the impact of peg discontinuation on risk of relapse?
For patients not on study, would you consider replacing missed doses of peg with a non-asparaginase based chemotherapy?
New comment
by at Cleveland Clinic Children's Hospital ( February 7, 2023)
Thank you Dr. @Paul Harker-Murray, this is helpful.
Read more (2 Answers available)
10775
×
To continue please login or register
Register
or
Sign in